---
figid: PMC2964177__hyq08405
figlink: /pmc/articles/PMC2964177/figure/HYQ084F5/
number: Figure 5
caption: Molecular crosstalk between the ER and ErbB1/ErbB2 cellular signaling pathways
  in endocrine-resistant ErbB2-positive breast cancer cells. Estrogen bound to the
  ER activates estrogen-regulated genes via a classical signaling pathway. ErbB1/ErbB2
  stimulation by growth factors results in activation of the PI3K/Akt and MAPK signaling
  pathways, leading to tumor cell growth. Long-term tamoxifen therapy may promote
  endocrine resistance via bidirectional crosstalk between the ER and growth factor
  receptor (i.e. IGF-1R or ErbB1/ErbB2) signaling pathway components. Bidirectional
  activation of these pathways promotes ER phosphorylation and ER target gene transcription
  as well as ErbB1/ErbB2/MAPK-mediated signaling and IGF-1R-mediated PI3K/Akt growth
  signaling pathways. Modulation of these pathways by combined use of lapatinib and
  anti-estrogen therapy (e.g. letrozole) may overcome endocrine resistance. CBP, cAMP
  response element binding protein (CREB)-binding protein; ER, estrogen receptor;
  ErbB1, human epidermal growth factor receptor 1; ErbB2, human epidermal growth factor
  receptor 2; mitogen-activated protein kinase; MEK, mitogen-activated protein kinase
  kinase; P, phosphate; p90RSK, p90 ribosomal S6 kinase; p160, p160 steroid receptor
  co-activator protein(s); PI3K, phosphatidylinositol-3-kinase; PTEN, phosphatase
  and tensin homologue deleted on chromosome 10; RAF, murine leukemia viral oncogene
  homologue 1; SOS, son-of-seven less guanine nucleotide exchange factor. Figure adapted
  from the publication by Johnston () (Fig. ) with permission from the American Association
  for Cancer Research.
pmcid: PMC2964177
papertitle: 'Management of ErbB2-positive Breast Cancer: Insights from Preclinical
  and Clinical Studies with Lapatinib.'
reftext: Charles Vogel, et al. Jpn J Clin Oncol. 2010 Nov;40(11):999-1013.
pmc_ranked_result_index: '35076'
pathway_score: 0.9661658
filename: hyq08405.jpg
figtitle: Molecular crosstalk between the ER and ErbB1/ErbB2 cellular signaling pathways
  in endocrine-resistant ErbB2-positive breast cancer cells
year: '2010'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2964177__hyq08405.html
  '@type': Dataset
  description: Molecular crosstalk between the ER and ErbB1/ErbB2 cellular signaling
    pathways in endocrine-resistant ErbB2-positive breast cancer cells. Estrogen bound
    to the ER activates estrogen-regulated genes via a classical signaling pathway.
    ErbB1/ErbB2 stimulation by growth factors results in activation of the PI3K/Akt
    and MAPK signaling pathways, leading to tumor cell growth. Long-term tamoxifen
    therapy may promote endocrine resistance via bidirectional crosstalk between the
    ER and growth factor receptor (i.e. IGF-1R or ErbB1/ErbB2) signaling pathway components.
    Bidirectional activation of these pathways promotes ER phosphorylation and ER
    target gene transcription as well as ErbB1/ErbB2/MAPK-mediated signaling and IGF-1R-mediated
    PI3K/Akt growth signaling pathways. Modulation of these pathways by combined use
    of lapatinib and anti-estrogen therapy (e.g. letrozole) may overcome endocrine
    resistance. CBP, cAMP response element binding protein (CREB)-binding protein;
    ER, estrogen receptor; ErbB1, human epidermal growth factor receptor 1; ErbB2,
    human epidermal growth factor receptor 2; mitogen-activated protein kinase; MEK,
    mitogen-activated protein kinase kinase; P, phosphate; p90RSK, p90 ribosomal S6
    kinase; p160, p160 steroid receptor co-activator protein(s); PI3K, phosphatidylinositol-3-kinase;
    PTEN, phosphatase and tensin homologue deleted on chromosome 10; RAF, murine leukemia
    viral oncogene homologue 1; SOS, son-of-seven less guanine nucleotide exchange
    factor. Figure adapted from the publication by Johnston () (Fig. ) with permission
    from the American Association for Cancer Research.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK9
  - KRAS
  - EGFR
  - MAPK8
  - MAPK11
  - RPS6KA2
  - RAF1
  - HRAS
  - NRAS
  - MAPK10
  - MAPK12
  - MAP2K1
  - OPN1LW
  - AKT1
  - MAPK1
  - MAPK3
  - MAPK14
  - PIK3R3
  - ARAF
  - SOS1
  - BRAF
  - AKT2
  - MAPK13
  - ERBB2
  - AKT3
  - RPS6KA1
  - MAP2K2
  - RPS6KA5
  - IGF1R
  - PIK3R6
  - PIK3CG
  - PIK3R5
  - RPS6KA3
  - RPS6KA6
  - SOS2
  - PIK3R4
  - MYBBP1A
  - PIK3CA
  - PIK3CD
  - RPS6KA4
  - PIK3CB
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: ErbB1/ErbB2
  symbol: ERBB1
  source: hgnc_alias_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA2
  entrez: '6196'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: CBP
  symbol: CBP
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1LW
  entrez: '5956'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: ErbB1/ErbB2
  symbol: ERBB2
  source: hgnc_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA5
  entrez: '9252'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA3
  entrez: '6197'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA6
  entrez: '27330'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: p160
  symbol: P160
  source: hgnc_alias_symbol
  hgnc_symbol: MYBBP1A
  entrez: '10514'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA4
  entrez: '8986'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
